tradingkey.logo

Cryoport Inc

CYRX
9.740USD
-0.010-0.10%
收盘 12/23, 16:00美东报价延迟15分钟
487.67M总市值
7.73市盈率 TTM

Cryoport Inc

9.740
-0.010-0.10%

关于 Cryoport Inc 公司

Cryoport, Inc. provides temperature-controlled supply chain solutions for the Life Sciences, with an emphasis on regenerative medicine. The Company supports biopharmaceutical companies, contract manufacturers (CDMOs), contract research organizations (CROs), developers, and researchers with a comprehensive suite of services and products. Its integrated supply chain platform includes the Cryoportal Logistics Management Platform, advanced temperature-controlled packaging, informatics, specialized biologistics, biostorage, bioservices, and cryogenic systems. The Company's segments include Life Sciences Services and Life Sciences Products. The Company's Life Sciences Services segment provides cryogenic biostorage within the life science industry through direct sales. Its Life Sciences Products segment manufactures and sells cryogenic freezers, cryogenic dewars and accessories within the life science industry through direct sales or a distribution network.

Cryoport Inc简介

公司代码CYRX
公司名称Cryoport Inc
上市日期Jul 24, 2015
CEOShelton (Jerrell Wilson)
员工数量1090
证券类型Ordinary Share
年结日Jul 24
公司地址112 Westwood Place, Suite 350
城市BRENTWOOD
上市交易所NASDAQ OMX - NASDAQ BASIC
国家United States of America
邮编37027
电话19492321900
网址https://www.cryoport.com/
公司代码CYRX
上市日期Jul 24, 2015
CEOShelton (Jerrell Wilson)

Cryoport Inc公司高管

名称
名称/职务
职务
持股
持股变动
Mr. Jerrell Wilson (Jerry) Shelton
Mr. Jerrell Wilson (Jerry) Shelton
Chairman of the Board, President, Chief Executive Officer
Chairman of the Board, President, Chief Executive Officer
1.00M
+2.56%
Mr. Daniel M. (Dan) Hancock
Mr. Daniel M. (Dan) Hancock
Independent Director
Independent Director
45.86K
+102.52%
Ms. Linda Baddour
Ms. Linda Baddour
Independent Director
Independent Director
44.90K
+107.03%
Dr. Robert J. (Bob) Hariri, M.D., Ph.D.
Dr. Robert J. (Bob) Hariri, M.D., Ph.D.
Independent Director
Independent Director
38.43K
+186.15%
Mr. Mark Sawicki
Mr. Mark Sawicki
Senior Vice President, Chief Scientific Officer
Senior Vice President, Chief Scientific Officer
--
--
Dr. Ramkumar Mandalam, Ph.D.
Dr. Ramkumar Mandalam, Ph.D.
Independent Director
Independent Director
--
--
Mr. Robert S. Stefanovich
Mr. Robert S. Stefanovich
Chief Financial Officer, Senior Vice President, Chief Administrative Officer
Chief Financial Officer, Senior Vice President, Chief Administrative Officer
--
--
Mr. Ram M. Jagannath
Mr. Ram M. Jagannath
Independent Director
Independent Director
--
--
Mr. Scott Eckstein
Mr. Scott Eckstein
Investor Relations
Investor Relations
--
--
Mr. Edward J. Zecchini
Mr. Edward J. Zecchini
Senior Vice President, Chief Digital and Technology Officer
Senior Vice President, Chief Digital and Technology Officer
--
--
名称
名称/职务
职务
持股
持股变动
Mr. Jerrell Wilson (Jerry) Shelton
Mr. Jerrell Wilson (Jerry) Shelton
Chairman of the Board, President, Chief Executive Officer
Chairman of the Board, President, Chief Executive Officer
1.00M
+2.56%
Mr. Daniel M. (Dan) Hancock
Mr. Daniel M. (Dan) Hancock
Independent Director
Independent Director
45.86K
+102.52%
Ms. Linda Baddour
Ms. Linda Baddour
Independent Director
Independent Director
44.90K
+107.03%
Dr. Robert J. (Bob) Hariri, M.D., Ph.D.
Dr. Robert J. (Bob) Hariri, M.D., Ph.D.
Independent Director
Independent Director
38.43K
+186.15%
Mr. Mark Sawicki
Mr. Mark Sawicki
Senior Vice President, Chief Scientific Officer
Senior Vice President, Chief Scientific Officer
--
--
Dr. Ramkumar Mandalam, Ph.D.
Dr. Ramkumar Mandalam, Ph.D.
Independent Director
Independent Director
--
--

收入明细

单位: USD更新时间: 10月6日 周一
单位: USD更新时间: 10月6日 周一
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021
FY2020
FY2019
FY2018
业务USD
名称
营收
占比
Life Science products
21.09M
46.39%
BioLogistics solutions
19.87M
43.72%
BioStorage/Bioservices
4.50M
9.89%
地区USD
名称
营收
占比
Americas
33.24M
73.12%
Asia Pacific
6.38M
14.04%
Europe & Middle East & Africa (EMEA)
5.83M
12.83%
业务
地区
业务USD
名称
营收
占比
Life Science products
21.09M
46.39%
BioLogistics solutions
19.87M
43.72%
BioStorage/Bioservices
4.50M
9.89%

股东统计

更新时间: 11月17日 周一
更新时间: 11月17日 周一
持股股东
股东类型
持股股东
持股股东
占比
Cadian Capital Management LP
9.95%
Morgan Stanley & Co. LLC
9.11%
BlackRock Institutional Trust Company, N.A.
6.74%
The Vanguard Group, Inc.
5.71%
Brown Capital Management, LLC
5.24%
其他
63.25%
持股股东
持股股东
占比
Cadian Capital Management LP
9.95%
Morgan Stanley & Co. LLC
9.11%
BlackRock Institutional Trust Company, N.A.
6.74%
The Vanguard Group, Inc.
5.71%
Brown Capital Management, LLC
5.24%
其他
63.25%
股东类型
持股股东
占比
Investment Advisor
42.57%
Investment Advisor/Hedge Fund
25.43%
Hedge Fund
22.33%
Research Firm
11.05%
Individual Investor
3.99%
Bank and Trust
0.67%
Sovereign Wealth Fund
0.43%
Pension Fund
0.42%
Family Office
0.10%

机构持股

更新时间: 12月8日 周一
更新时间: 12月8日 周一
报告期
机构数
持股数
持股占比
持股变动
2025Q4
365
51.44M
117.38%
--
2025Q3
382
51.46M
118.49%
+897.37K
2025Q2
395
50.60M
125.22%
-144.83K
2025Q1
397
50.53M
128.31%
-13.51M
2024Q4
394
50.41M
130.61%
-180.77K
2024Q3
409
50.54M
130.03%
-5.26M
2024Q2
410
52.11M
125.57%
-2.50M
2024Q1
424
53.98M
124.33%
-7.14M
2023Q4
457
52.70M
119.71%
+4.70M
2023Q3
471
48.09M
113.05%
-102.80K
查看更多

股东持股明细

名称
持股数
占比
持股变动
变动比例
公告日期
Cadian Capital Management LP
4.97M
9.93%
-12.80K
-0.26%
Jun 30, 2025
Morgan Stanley & Co. LLC
4.55M
9.08%
-60.87K
-1.32%
Jun 30, 2025
BlackRock Institutional Trust Company, N.A.
3.41M
6.8%
+151.66K
+4.66%
Jun 30, 2025
The Vanguard Group, Inc.
2.79M
5.57%
+43.03K
+1.57%
Jun 30, 2025
Brown Capital Management, LLC
3.80M
7.59%
-254.65K
-6.28%
Jun 30, 2025
Millennium Management LLC
2.56M
5.12%
+350.15K
+15.83%
Sep 24, 2025
Fred Alger Management, LLC
2.36M
4.71%
-173.42K
-6.85%
Jun 30, 2025
Thematics Asset Management SAS
1.66M
3.32%
+1.04M
+168.96%
Mar 31, 2025
Natixis Investment Managers SA
1.91M
3.82%
+216.94K
+12.78%
Jun 30, 2025
Assenagon Asset Management S.A.
1.50M
2.99%
+408.26K
+37.44%
Sep 30, 2025
查看更多

持股ETF

更新时间: 12月6日 周六
更新时间: 12月6日 周六
机构名称
占比
Invesco NASDAQ Future Gen 200 ETF
0.56%
Inspire Small/Mid Cap ESG ETF
0.21%
JPMorgan Fundamental Data Science Small Core ETF
0.1%
Avantis US Small Cap Equity ETF
0.05%
Vanguard US Momentum Factor ETF
0.04%
Goldman Sachs ActiveBeta US Small Cap Equity ETF
0.03%
Global X Russell 2000 ETF
0.02%
ProShares UltraPro Russell2000
0.02%
Invesco RAFI US 1500 Small-Mid ETF
0.02%
ProShares Hedge Replication ETF
0.02%
查看更多
Invesco NASDAQ Future Gen 200 ETF
占比0.56%
Inspire Small/Mid Cap ESG ETF
占比0.21%
JPMorgan Fundamental Data Science Small Core ETF
占比0.1%
Avantis US Small Cap Equity ETF
占比0.05%
Vanguard US Momentum Factor ETF
占比0.04%
Goldman Sachs ActiveBeta US Small Cap Equity ETF
占比0.03%
Global X Russell 2000 ETF
占比0.02%
ProShares UltraPro Russell2000
占比0.02%
Invesco RAFI US 1500 Small-Mid ETF
占比0.02%
ProShares Hedge Replication ETF
占比0.02%

分红派息

近5年累计派现 0.00 美元
公告日期
分红计划
股权登记日
现金发放日
除权除息日
暂无数据

拆合股

公告日期
类型
比率
暂无数据
公告日期
类型
比率
暂无数据

常见问题

Cryoport Inc的前五大股东是谁?

Cryoport Inc 的前五大股东如下:
Cadian Capital Management LP持有股份:4.97M,占总股份比例:9.93%。
Morgan Stanley & Co. LLC持有股份:4.55M,占总股份比例:9.08%。
BlackRock Institutional Trust Company, N.A.持有股份:3.41M,占总股份比例:6.80%。
The Vanguard Group, Inc.持有股份:2.79M,占总股份比例:5.57%。
Brown Capital Management, LLC持有股份:3.80M,占总股份比例:7.59%。

Cryoport Inc的前三大股东类型是什么?

Cryoport Inc 的前三大股东类型分别是:
Cadian Capital Management LP
Morgan Stanley & Co. LLC
BlackRock Institutional Trust Company, N.A.

有多少机构持有Cryoport Inc(CYRX)的股份?

截至2025Q4,共有365家机构持有Cryoport Inc的股份,合计持有的股份价值约为51.44M,占公司总股份的117.38%。与2025Q3相比,机构持股有所增加,增幅为-1.11%。

哪个业务部门对Cryoport Inc的收入贡献最大?

在FY2025Q2,Life Science products业务部门对Cryoport Inc的收入贡献最大,创收21.09M,占总收入的46.39%。
KeyAI